Carl Zeiss Meditec (ETR:AFX) Trading 0.4% Higher – What’s Next?

Carl Zeiss Meditec AG (ETR:AFX)’s share price traded up 0.4% on Monday . The stock traded as high as €28.36 and last traded at €27.84. 244,396 shares traded hands during mid-day trading, an increase of 159% from the average session volume of 94,405 shares. The stock had previously closed at €27.74.

Carl Zeiss Meditec Price Performance

The company has a debt-to-equity ratio of 28.70, a current ratio of 2.35 and a quick ratio of 2.47. The firm has a market capitalization of $2.60 billion, a P/E ratio of 14.91, a P/E/G ratio of 2.83 and a beta of 1.41. The firm’s 50 day simple moving average is €25.54 and its two-hundred day simple moving average is €35.20.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.